Table 1.
Table of LG endocarditis cases described in the literature (incidence, demographics, type, risk factors, antibiotics, surgery, outcome).
| Reference | Acquired Infection Location | Sex/Age | Type | Risk Factors | Antibiotics | Surgery | Outcome |
|---|---|---|---|---|---|---|---|
| Navas et al13 | USA | Male/64 | NAV | VAN | Yes | Survival | |
| Ortiz et al25 | Spain | Female/70 | NMV | AMX + GEN | Yes | Survival | |
| Ortiz et al25 | Spain | Female/77 | NMV/NAV | GD | AMX + GEN | No | Death |
| Backes et al26 | Holland | Female/68 | NAV | GD | No | Survival | |
| Zuily et al8 | France | Female/64 | PMV | RF/GD | AMX + GEN | No | Survival |
| Heras et al27 | Spain | Male/68 | NMV | GEN + AMP + CTX | Yes | Death | |
| Watanabe et al17 | Japan | Female/55 | NMV | PEN + GEN, CTX + GEN | No | Survival | |
| Li et al12 | China | Male/41 | NMV | PEN + GEN | Yes | Survival | |
| Clavero et al28 | Chile | Female/72 | NMV | RF | AMP + CLX, VAN + GEN | No | Death |
| Rasmussen et al29 | Sweden | Male/81 | PAV/NMV | GD | PEN + TOB | No | Survival |
| Bazemore et al30 | USA | Male/45 | PAV | GD | VAN + Pip/Taz, CTX + GEN | Yes | Survival |
| James et al22 | UK | Female/56 | PAV | VAN | No | Survival | |
| Tsur et al31 | Israel | Male/76 | PAV | GD | CTX + GEN | No | Survival |
| Russo et al1 | Italy | Male/63 | PAV/NMV | GD | VAN + GEN, AMP + GEN | No | Survival |
| Hirakawa et al32 | Brazil | Female/58 | PMV | RF | VAN | No | Survival |
| Suh et al33 | Korea | Female/75 | PMV | RF | CTX + GEN + RI, TEI + CTX | Yes | Survival |
| Wilbring et al34 | Germany | Male/55 | PTV | VAN + GEN, AMX + LEV | No | Survival | |
| Landeloos et al35 | Belgium | Female/82 | PMV | GD | AMX, PEN + GEN | No | Survival |
| Lim and Jenkins36 | UK | Male/57 | NMV | GD | AMX + GEN | Yes | Survival |
| Wang et al37 | China | Male/72 | NMV | RF/GD | PEN + GEN | No | Survival |
| Fleming et al18 | Korea | Male/68 | PAV/NMV | RF/GD | VAN | No | Death |
| Fihman et al21 | France | Female/86 | PAV | GD | AMX + GEN | No | Survival |
| Vinh et al6 | Canada | Male/80 | NAV | GD | AMP | Yes | Survival |
| Yiu et al38 | China | Male/67 | NMV | AMP | Yes | Survival | |
| Fefer et al39 | USA | Female/84 | NMV/PAV | CTX | Yes | Death |
Abbreviations: NAV, native aortic valve; VAN, vancomycin; NMV, native mitral valve; AMX, amoxicillin; GEN, gentamicin; GD, gastrointestinal disorder; PMV, prosthetic mitral valve; RF, raw fish; AMP, ampicillin; CTX, ceftriaxone; CLX, cloxacillin; PAV, prosthetic aortic valve; PEN, penicillin; TOB, tobramycin; Pip/Taz, piperacillin/tazobactam; RI, rifampicin; TEI, teicoplanin; PTV, prosthetic tricuspid valve; LEV, levofloxacin.1,6,8,12,13,17,18,21,22,25-39